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Objectives. This study was designed to evdnate the long-*emu 
e&z& ol combination tbampy with an angjotensinanverting 
enzyme inhibitor and a beta-adrenergic blocking agent on Ihe 
relation between the decrease in orterlal pressure at reSt and 
during exercise and the decrease in kit ventricular mass. 
been shown to reduce ventricular h~>rtmphy, although little b 
kom+n about combtoation therapy and the time course of such o 
reduction. 
Metbodr. Twentyone patients with previously untreated aeon. 
tiat bypertenrian were treated with a tw doso combination of 
50 me of atenolot and lo me of enalsor” once dattv tar 39 rxxmtbs. 
Card&cul~r findings were as&d by tw&bnansiooally 
mdded M.mode echoeerdiwraohv totke oretreatment ohw and 
&er 6 and 39 modhs of combination &rapy. 
ResuuS. Combination therapy reduced arterial pressure at rest 
tram 1611108 to ISoB6 mm “g @ < O.oOt, and exe&e arterial 
The combination of beta-wirer&c blocking agents and 
angiotensinconvening enzyme inhibitors in antihyperten- 
sive therapy is controversial. Whereas some studies demon- 
strated an additional antihyper*ensive ffect when these two 
classes of agents were combixd (1.21, others showed no 
such effect (3,4). Both classes of agents exert their antihy- 
wtterlsive effect to sane ex!:nt bv intetferine with the 
gctivity of the renin.angiotensin-aldosterone &de. Also, 
both classes of ageots have been shown to reduce left 
ventricular hypertraphy (S-10) although the mechanism of 
this reduction may not be similar and its magnitude does not 
rsem to correlate with the antihypertensive tfect. 
The present study was designed to evaluate the long-term 
effects of combination therapy with an aogiotensin- 
convening eozyme inhibitor and a beta-blocker on the 
relation between the fall in arterial pressure, at rest and 
pwsure at loo W from 1921112 to 167195 nun Hg (p < 0.001). 
After 6 months al treatment, sigoiltcaot decreases toInterventric. 
alar septol thickness (9% p < O.GDl), pmterior wall thlckoers 
(9%, p C 0.001) and left veotrtcular massindex (16%, p < O.Oal) 
were demonstrated 011 the ecbwrrdioeram. After 39 mantbs of 
,berq,y, reduclions in these valuer w&e 28% (p < O.oOl), 29% 
(p < O.OOI) and 40% (o < O.WI), respectively. 
Conclusion& Lonb?&m lreabnent with coothiootitiOn therapy 
ti ateooJo1 and enataprtt produced rigoificaot reductiins to arte 
rial proswe at rert and during exercise accompanied by a marked 
rfdnction of teh venwtculsr mass. Amwrr, whereas art&t 
prwure decrearad bmmedlatety and remsined unchsnged. kft 
ventrtcuhr mass dnreasxd more gradnatty and contiiued to 
deereasp lhmughout the Irenhnent @ad of >3 years. Despite 
this marked reduction to let! ventrtcutor out, left ventrlcutar 
pump fimctton was wet, presxwd during rePt and exercise. 
during dynamic and isometric exercise, and the decrease in 
Left mass. 
Methods 
PaIients. Twenty-one previously untreated hypertensive 
patients (18 mole, 3 female; mean age 43.3 t 8.4 years [range 
28 to 561) porttcipated in the study after giving informed 
consent. All patients had casual measure~~ents of arterial 
pressue greater than 140190 mm Hg a, three separate 
n~easurement~ and .m increased preosuw response during 
and after standardized exercise (11.12). Left ventricular 
hypertrophy was detined by echocardiographic measure- 
ments (septal thickness and posterior wall thickness in 
end.diastole 21 I mm; left vent&ular mm index >I25 s/t&) 
(13). No subject had evidence of heart failure, mvocardial 
infarction. angina pectcris or valvular heart diseases. 
After t!te initial pretreatment study. the patients were 
treated with a combination of 50 mg of atenolol and IO mg of 
eoalapril ~oce daily. This dose remained constant over a 
period of 38.5 + 0.9 months. Rest dnd exercise oneriot 
prersure were measured and echocardiogmphic studies were 
performed before treatment. 
decreasc in arterial pressure to <: 14Ol90 mm Hg at rest and to 
<200/100 mm H8 at a 100-W work load after 4 weeks of 
antiiyperlensive therapy. Echocardiographic and arterial 
pressure mcasurcmenrs WOR repeated after 6.7 2 0.7 and 
after 38.9 f 0.9 months of treatment. 
Exeretse testing. The patients were swdied under identi- 
cal conditions with techniques given in the “Proposal for 
international Standardization of Eraometrv” (14). On each 
Occasion, the patients exercised at ihe s&e time. approxi- 
mately 3 h after controlled administration of the drugs. The 
exercise was oerformed in a reclined Wine. oosnion oo a 
bicycle ergorn&r (ERG 301. Roben Bosch)‘with a pedal 
frequency of JO cycleslmin. starting at 50 W with IO-W 
in&n& every minute up to amaximum of 100 W. 
Arterial pressure response to isometric exercise, which 
involved holding a 2.4-kg weight in the left hand with the arm 
extended horizontally. was measured 3.5 h after the last 
dose. 
Arterial pressure and heart rate wasttremeala. Casual 
antial pressure readings were taken after 5 min of rest in 
the supine position &in rbe standing @lion I min after 
rising: the recorded valuer were the mean of two measure- 
ments. Daring exercise and 5 min thereafter. readings were 
taken every minute by using a sphygmomanometer (phase 
IV for diastolic pressure). All readings were made by the 
same investigator using the same calibrated mercury ma- 
nometer. The heart rate was obtained from the electrocar- 
diwram, which was recorded in the last 10 s of every 
minute. 
Rchwart&mphy. M-mode echocardiography was per- 
formed with two-dimensional monitoring using an ultmsono- 
cope (model Sonotroa 3408 R, Diasonics) with a 2.4-MHz 
transducer. The patients were examined in the left lateral 
position with the head of the bed tilted by 30”. Two- 
dimensional echocardiograph! us used in the parastemzd 
long-axis view to select the site for the M-mode ecbwzardia- 
araohic measurements. Measurements were made at the tips 
&he mitral valve leak with the transducer perpendicular 
to the chest wall. Left ventricular internal dimension. IeR 
venttiw!sr septal thiclotess and postericr wall thickness 
were measured by the - investigator according to the 
rs~mmcndatioru of the American Sxiety of Echocardiog 
raphy (iS). All twawrements were p-erfot~~~ed from at le%l 
two sets of +6 conscculive cardiac cycles by two observers 
who had no knowledge of ether patient data. Left venbicula~ 
mass was estimated by the -formula of Devereux and 
Reicheck (13) and was divided by the body surface area to 
derive the left venuictdar mass index. The relative wall 
thickness was c&dated at end-diasralc by the f&owing 
ratio: Relative wall thickness = 2x Poster& wall thick& 
- Left ventricular internal dimension. 
Before and during long-term treatment, peripheral venous 
blood was drawn from the antecubital fossa for routine 
hematologic and biochemical investigations. All mean values 
are given with 1 SD. Statistical analysis was performed by 
using the Wilcoxon test. 
ReSUll§ 
Arterial -. The averace arterial oressure of 161 f 
181108 + icmm Hg during the$ac&a p&d was reduced 
to 127 ? 15184 ? IO mm He lo < O.ODll after 4 weeks of 
I ,. 
treatment and remained unchanged aft& 6.7 months and 
after 39 months of therapy (Table I, Fig. 1). An&al pressure 
at a IO&W work load was also reduced. from I92 2 1511 I2 f 
8 to I59 f 14194 + 12 mm Hg (p < 0.001) after 4 weeks of 
therapy, and remained reduced to the same extent after 39 
Figwe,. EBctra:4weekr,6manthrand3y_dueatolentuith 
a combination ofatenolol and enalapril on art&l pressure at rent 
and during dyeamk and ikern& exercise. 
ment. The side effects were minimal, and only two patients 
had to be withdrawn from the study after shcl-term treat- 
ment. One developed drup-related erythema and the other 
reported a decrease in physical performance. 
Flgwr 2. Time course of percent reduction of left ventricular mass 
and arterial PIIS”K during er8omctric exercise (lea W) With a 
combination uf atenolol and enalapril. DBP = diaslolic blood 
pressure: LVMI = left ventricular mws index: SBP = systolic blood 
pressure. 
months (Table I, Fig. I and 2). A similar arterial pressure 
response was demonstrated uring isometric exercise (Table 
2, big. 1): baseline and exercire levels of arterial Pressure 
decreased with antihypertensive therapy. but the magnitude 
of the response remained unchanged. 
&howdiographic indexes. After a mean average treat- 
ment period of 6.1 months, there was a decrease of 9% in 
interventricular xptal thickness and posterior wall thick- 
ness, as well as a 16% decrease in ieft ventricular mass index 
(all P C 0.001) (Table 3. Fig. 3). In the follow-up period of 39 
months, there were forther decreases to a reduction of m 
in left ventricular mass, 28% in interventricular septal thick- 
ness and 29% in posterior wall thickness (p < 0.001 com- 
pared with pretreatment placebo values) (Table 3. Fig. 2 and 
3j. in addition to the reduction in the absolute values of wall 
thickness, there was a reduction in relative wall thickness 
ID < o.Ow. 
Left ventricular end-systolic dimension decreared, but 
I& ventricular end-diastolic dimension did not change after 
long-term treatnxat. Fractional lioer shortening and &ction 
fraction remained unchanged after 6.7 months but were 
significantly increased (p < 0.0s and p < O.Wl, respectively) 
cwer placebo levels after 39 months of treatment (Table 3). 
Adverse effectz. Combination therapy did not influence 
total cholesterol, low density lipoprotein cholesterol or 
triglyceride levels, whereas the high density lipoprotein 
cholesterol level decreased sliihtly after long-term treat- 
Discussion 
The present study derllon8trate8 that longterm treatment 
with a beta-blocker and an angiotensin-converting enzyme 
inhibitor significantly lowered arterial pressure during rest 
and exercise and reduced left ventricular hypertrophy. Pre- 
vious data from our group demonstrated that additional 
antihypertensive efficacy could be achieved if a beta- 
hlockef, such as atenolol, was added to an qiotensin- 
converting enzyme inhibitor, such as enalapril (16). As 
demonstrated in this study, the antihypertensive ffect of 
combination therapy was sustained at rest and with dynamic 
as well as isometric exercise for a period of 3 years. 
Et&z* of left ventricular - redurtion on venlrtcular 
panP function. Left ventricular mass was found to be 
reduced by 16% after 6 months of antihypertensive therapy. 
A reduction in left ventricular mass to a similar extent has 
been reported in other short-term studies (l7,lS) with moao- 
therapy usi@ anglotensikconverting enzyme inhibitors, 
beta-blockers and calcium channel antagonists. However. in 
the present study, left ventricular mass continued to de- 
crease with continuous antihypertensive therapy, and after 3 
years was 40% less than pretreatment values. One may 
appropria:e!y ssk at this juncture how “physiologic” such a 
marked reduction of left ventricular mass could be. In the 
past concern has been expressed (IV) that as one reduces left 
ventricular ma88 with specific antihypertensive therapy, one 
would predominantly reduce myocardial muscle mass and 
leave supportive (i.e., fibrotic) tissue unatTe.cted. Indeed, in 
hypertensive rats a hither degree of fibrotic tissue and 
diminished inotmpic reserve of the heart was demonstrated 
after reduction of ieft ventricular mass (19). Although the 
present study was not desiaaed to specifically test this 
hypothesis, it is reassuring to note that after a 40% reduc:ion 
of left ventricular mass all patients were able to tolerate 
maximal exercise levels of 100 W with peak systolic arterial 
Pressure levels that were only IS% lower during aatihypcr- 
tensive therapy than in the pretreatment period. This indi- 
cates that the left ventricle. after a 40% reduction in left 
ventricular mass, is capable of bearing the hemcdynamic 
burden of a heavy isometric or dynamic work load. Similar 
data attesting to a good contractile performance after reduc- 
tion of left ventricular mass were documented in several 
other studies (6.20-24). including one from our group (25). 
even after the patient had discontinued antihypertensive 
therapy and arterial pressure had returned to pretreatment 
levels. 
Time course of reduclion in left ventricular mass. The 
oresent data indicate that the wriod of 3 TV b months used in 
most studies is insufficient td document the time course of 
;&‘. venticularmass and to reach baseline levels. Hanford et 
al. (26) have documented that left ventricular mass conlin- 
ued lo decrease during a treatment period of 24 months. 
However, neither our study nor the study by Hartford et al. 
Fii 3. Regression of left venbicular mass during IonSwm 
wrlment with a combination of arenolal and enalapnl. IVST = 
interventricular septal tbicknerr: LVM = left ventricular mea 
index: FWT = posterior wall thickness: RWT = relative wall 
thickness. 
allows US to clearly identify the time course of reduction in 
left ventricularmars, whichdoesnot seemtobelinked to the 
time ccurse of reduction in arterial pressure. 

